In vivo evidence that the increase in matrix metalloproteinase activity occurs early after cerebral ischemia

Molecular Imaging

Volumn 11, Issue 1, 2012, Pages 22-26

  Martín, Abraham ^a   Garofalakis, Anikitos ^a   Tavitian, Bertrand ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBRAL ISCHEMIA; CEREBRAL TISSUES; EX-VIVO; FLUORESCENCE DIFFUSE OPTICAL TOMOGRAPHY; IN-VIVO; ISCHEMIC STROKES; MATRIX METALLOPROTEINASES; MMP ACTIVITY;

OPTICAL TOMOGRAPHY; TISSUE;

ENZYME INHIBITION;

MATRIX METALLOPROTEINASE;

ANIMAL; ARTICLE; BRAIN; BRAIN ISCHEMIA; C57BL MOUSE; COMPUTER ASSISTED TOMOGRAPHY; ENZYMOLOGY; MALE; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; BRAIN; BRAIN ISCHEMIA; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84857353057     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2011.00023     Document Type: Article

References (15)

1. Hacke W, Marler J. TPA in acute stroke. Eur Heart J 1997;18:1360.
2. Montaner J, Alvarez-Sabín J, Molina C, et al. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke 2001;32:2762-7, doi:10.1161/hs1201. 99512. (Pubitemid 33134461)
3. Copin JC, Goodyear MC, Gidday JM. Role of matrix metalloproteinases in apoptosis after transient focal cerebral ischemia in rats and mice. Eur J Neurosci 2005;22:1597-608, doi:10.1111/j.1460-9568.2005.04367.x. (Pubitemid 41482948)
4. Zhao BQ, Wang S, Kim HY, et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 2006;12:441-5, doi:10.1038/nm1387.
5. Rosell A, Lo EH. Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol 2008;8:82-9, doi:10.1016/j.coph.2007.12.001.
6. Ntziachristos V, Tung C, Bremer C, et al. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 2002;8:757-60, doi:10.1038/nm729. (Pubitemid 34778731)
7. Klohs J, Baeva N, Steinbrink J, et al. In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia. J Cereb Blood Flow Metab 2009;29:1284-92, doi:10.1038/jcbfm.2009.51.
8. Justicia C, Panés J, Solé S, et al. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab 2003;23:1430-40, doi:10.1097/01.WCB.0000090680.07515.C8. (Pubitemid 38018261)
9. Gasche Y, Fujimura M, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab 1999;19:1020-8, doi:10.1097/00004647-199909000-00010. (Pubitemid 30173725)
10. Garofalakis A, Dubois A, Kuhnast B, et al. In vivo validation of free-space fluorescence tomography using nuclear imaging. Opt Lett 2010;35:3024-6, doi:10.1364/OL.35.003024.
11. Hervé L, Koenig A, Da Silva A, et al. Noncontact fluorescence diffuse optical tomography of heterogeneous media. Appl Opt 2007;46:4896-906, doi:10.1364/AO.46.004896. (Pubitemid 47632043)
12. Engelter ST, Provenzale JM, Petrella JR, et al. Infarct volume on apparent diffusion coefficient maps correlates with length of stay and outcome after middle cerebral artery stroke. Cerebrovasc Dis 2003;15:188-91, doi:10.1159/000068826. (Pubitemid 36351204)
13. Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 2005;50:329-39, doi:10.1002/glia.20169. (Pubitemid 40780839)
14. Worthmann H, Tryc AB, Goldbecker A, et al. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome. Cerebrovasc Dis 2010;30:85-92, doi:10.1159/ 000314624.
15. Copin JC, Gasche Y. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats. Brain Res 2008;1243: 161-6.